![Novartis Unveils Major Acquisition of Anthos Therapeutics for $925 Million](/images/novartis-unveils-major-acquisition-of-anthos-therapeutics-for-925-million.webp)
Novartis Unveils Major Acquisition of Anthos Therapeutics for $925 Million
10 hours ago
In a strategic move aimed at enhancing its portfolio in the biopharmaceutical sector, Novartis has announced its decision to acquire Anthos Therapeutics, a company specializing in the development of innovative therapies for cardiovascular diseases. The acquisition deal, valued at approximately $925 million, marks a significant investment for Novartis as it seeks to bolster its research and development capabilities in a competitive market.
Continue reading